文献速递血液净化与透析

布洛芬与袢利尿剂在血液透析中清除蛋白结合尿毒症毒素的比较

Comparing Ibuprofen and Loop Diuretics for Protein-Bound Uremic Toxins Clearance During Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2026-07-28

该纵向交叉研究纳入12例慢性血液透析患者,比较6种透析模式对蛋白结合尿毒症毒素的清除效果。结果显示,动脉输注布洛芬是唯一显著提高吲哚硫酸和對甲酚硫酸清除率的策略,平均下降率分别为65%和60%(P<0.05 vs 基线OL-HDF),而袢利尿剂无显著效果。

要点

  • 动脉输注布洛芬显著提高IS和pCS清除率,RR分别为65%和60%。
  • 口服或动脉给予袢利尿剂未显著增加IS或pCS的下降率。
  • 药理学置换可能是优化蛋白结合尿毒症毒素清除的辅助策略。

核心结论

  • 预滤器动脉输注布洛芬是提高OL-HDF期间IS和pCS清除的最有效策略。
  • 袢利尿剂无效提示高容量HDF存在天花板效应,仅高亲和力竞争剂可进一步置换PBUTs。

研究设计与样本

  • 纵向交叉研究,纳入12例慢性血液透析患者。
  • 每例患者接受6种基于后稀释HDF的透析模式。

主要发现

  • 动脉输注布洛芬组IS平均RR为65%,pCS平均RR为60%(P<0.05 vs 基线OL-HDF)。
  • 口服或动脉给予袢利尿剂与OL-HDF相比,IS或pCS的RR无统计学显著增加。
  • 药物干预期间未报告急性不良事件。

关键数值与推荐

  • 实验组包括:标准后稀释HDF(对照)、高通量血液透析、透析前1小时口服呋塞米、透析前1小时口服托拉塞米、动脉输注呋塞米1小时、动脉输注布洛芬1小时。
  • 使用单因素重复测量方差分析及Bonferroni事后校正进行统计。

临床怎么用

  • 动脉输注布洛芬可作为提高OL-HDF清除IS和pCS的辅助手段,但需注意其临床安全性及长期获益尚未确立。
  • 袢利尿剂不推荐用于增强PBUTs清除。

局限性

  • 样本量小(12例),结论需更大规模研究验证。
  • 未报告布洛芬动脉输注的长期安全性及临床硬终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Protein-bound uremic toxins (PBUTs), such as indoxyl sulphate (IS) and p-cresyl sulphate (pCS) are associated with cardiovascular mortality in patients undergoing hemodialysis. Because of their high albumin affinity, conventional dialysis techniques achieve poor clearance. This study aims to evaluate the efficacy of different competitive binding displacement strategies using ibuprofen and loop diuretics during online hemodiafiltration (OL-HDF). METHODS: A longitudinal, cross-over study in 12 patients undergoing chronic hemodialysis was performed. Each patient underwent 6 different dialysis modalities based on postdilutional HDF. The experimental arms included the following: (i) Standard postdilutional HDF (control), (ii) High-flux hemodialysis (HF-HD) (iii) Oral furosemide 1h predialysis, (iv) Oral torasemide 1h predialysis, (v) 1h arterial infusion of furosemide, and (vi) 1h arterial infusion of ibuprofen. Reduction ratios (RR) for IS and pCS were calculated for each session. Statistical analysis was performed using 1-way repeated measures analysis of variance with Bonferroni post hoc correction. RESULTS: Arterial administration of ibuprofen was the only strategy that significantly enhanced PBUT removal, achieving mean RR of 65% for IS and 60% for pCS (P < 0.05 vs. baseline OL-HDF). In contrast, neither oral nor arterial administration of loop diuretics showed a statistically significant increase in the RR of IS or pCS when compared with OL-HDF. No acute adverse events were reported during the pharmacological interventions. CONCLUSION: Prefilter arterial infusion of ibuprofen is the most effective strategy for increasing the intradialytic clearance of IS and pCS during OL-HDF. The lack of efficacy observed with furosemide suggests a ceiling effect in high-volume HDF, where only high-affinity competitors can further displace PBUTs from albumin-binding sites. Pharmacological displacement represents a promising adjunct to convective therapies to optimize protein-bound uremic toxin removal.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Escudero-Saiz VJ, Cuadrado-Payán E, Rodríguez-García M, et al. Comparing Ibuprofen and Loop Diuretics for Protein-Bound Uremic Toxins Clearance During Hemodialysis. Kidney Int Rep. 2026. PMID: 42662542. doi:10.1016/j.ekir.2026.106994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。